Alpha Lipoic Acid - NutraPedia

Back to Table of Contents

Alpha Lipoic Acid (ALA)

1) Studied Conditions

Alpha Lipoic Acid has been studied for a variety of conditions, including:

Diabetic neuropathy
Weight loss
High cholesterol
High blood pressure
Chronic fatigue syndrome
Glaucoma
HIV/AIDS
Cancer
Alzheimer's disease
Multiple sclerosis

2) Effectiveness in Treating Conditions

While ALA has been studied for various conditions, its effectiveness varies:

It has shown some promise in improving symptoms of diabetic neuropathy.
There is limited evidence supporting its use for weight loss and reducing cholesterol.
More research is needed to confirm its effectiveness in other conditions.

3) Health Benefits

Alpha Lipoic Acid has several potential health benefits:

Acts as an antioxidant, potentially reducing oxidative stress.
May improve nerve function and reduce inflammation.
Could enhance glucose uptake in cells and help manage blood sugar levels.
Possibly supports mitochondrial function and energy production.

4) Downsides

Despite its potential benefits, ALA might have downsides:

May cause side effects like nausea, rash, and itching.
High doses could potentially interfere with treatments for thyroid diseases or cancer.
Can interact with certain medications, such as diabetes or thyroid medications.

5) Genetic Variations

Research on ALA's effects on specific genetic variations is limited. However, some points to consider include:

Individuals with certain genetic mutations might metabolize ALA differently.
People with inherited mitochondrial disorders may experience different effects from ALA supplementation.
It is important to consult a healthcare provider before taking ALA, especially if there is a known genetic variation that could impact its use.

Research Summary on Alpha Lipoic Acid

Alpha Lipoic Acid in Treating Burning Mouth Syndrome (BMS)

A meta-analysis of nine RCTs with 594 patients assessed the effectiveness of alpha-lipoic acid (ALA) for BMS. The primary outcome, pain intensity on the visual analog scale (VAS), showed no significant reduction compared to placebo. However, ALA was associated with almost twice the likelihood of symptom improvement. Treatments such as clonazepam and pregabalin were more effective than ALA. More research is needed for definitive treatment guidelines.

ALA and Multiple Sclerosis (MS)

Systematic reviews and analyses indicate that ALA may have protective effects against MS. ALA reduced inflammation and improved walking ability in MS patients with minimal adverse events. However, due to variability in study designs, further research is needed to establish ALA as a standard supplementary therapy for MS.

ALA's Role in MS Pathology

ALA exhibits beneficial effects in preventing monocyte migration and BBB dysfunction in MS pathology. It reduced the onset of clinical symptoms and leukocyte infiltration in CNS in a rat model, suggesting its potential as a therapeutic agent for MS treatment.

ALA Supplementation and Brain Atrophy in SPMS

A study on secondary progressive multiple sclerosis (SPMS) patients showed that 1200 mg of ALA daily reduced brain atrophy rates by 68% compared to a placebo group. The study found ALA safe and well-tolerated over two years, with high treatment compliance.

ALA in Diabetic Neuropathy

A systematic review of eight studies with 1,500 patients showed mixed results on the effectiveness of ALA in reducing symptoms of diabetic neuropathy. While ALA appears safe, its efficacy is not conclusively supported by the evidence.

ALA on Biological Markers of Diabetic Nephropathy

ALA supplementation led to a decrease in urinary albumin markers in diabetic patients, but the improvement was not significant when considering ALA alone. The evidence on ALA's impact on diabetic nephropathy is limited.

Effect of ALA Dose on Cardiometabolic Risk Factors

In type 2 diabetes patients, a systematic review and meta-analysis found that ALA supplementation led to reductions in HbA1c, body weight, CRP, fasting plasma glucose, and triglycerides. However, the clinical significance of these improvements was minimal.

ALA and Sperm Parameters

An analysis of three studies involving 133 participants showed that ALA treatment improved various sperm parameters. While indicative of potential benefits for male fertility, more rigorous trials are needed to confirm the findings.

ALA in Idiopathic Asthenozoospermia

A study on men with idiopathic asthenozoospermia found that ALA supplementation significantly improved sperm motility and concentration, suggesting potential benefits as an adjunct therapy for improving sperm quality.

ALA on Infertility

A review on ALA's effects on male and female infertility found that ALA may improve various reproductive outcomes. However, more clinical research is necessary to confirm its benefits.

ALA in Diabetic Polyneuropathy

The ALADIN II study indicated that ALA can improve nerve conduction in diabetic polyneuropathy, particularly at higher doses, suggesting a potential beneficial effect.

ALA and Vascular Function

Human intervention studies suggest ALA may improve endothelial function by reducing oxidative stress and inflammation, potentially mitigating cardiovascular disease. The impact on arterial stiffness needs further investigation.

ALA and Endothelial Function

A meta-analysis found that ALA supplementation significantly improved flow-mediated dilation (FMD), a marker of endothelial function. More research is needed to understand ALA's effects on other endothelial function biomarkers.

ALA and Insulin Autoimmune Syndrome (IAS)

Cases of IAS, a condition causing hypoglycemia due to autoantibodies against endogenous insulin, have been associated with ALA supplementation. Genetic predispositions, such as the HLA-DRB1*0403 haplotype, may increase the risk. Discontinuation of ALA leads to the resolution of IAS.

References:

Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!